Delaware Business Times Editor Katie Tabeling looks at the challenges many bioscience start-up companies face that seek to push boundaries in medical and scientific research.
The top life science conference “Delaware’s DNA” will be back this May, and in its second year it will focus on how deep the roots of Delaware’s bioscience industry goes.
Padraig McDonnell has been named as the next CEO of Agilent, as its current leader Mike McMullen prepares to retire.
To continue to develop cutting-edge treatments to cure cancer and other serious issues, Delaware's bioscience companies look for the best team possible and those who believe in their mission.
After collaborating with MorphoSys on a developing cancer treatment Monjuvi, Incyte has bought full rights to develop the immunotherapy and bring it to market.
Prelude Therapeutics cut the ribbon on its new headquarters on Friday morning, signaling the next chapter in the company's growth.
CorriXR has secured an undisclosed amount of funding from Cortado Ventures, bringing it closer to clinical trials.
Agilent Technologies and Incyte have signed an agreement to create companion diagnostics tests, bringing the two Delaware companies together in the future of cancer treatments.
Synnovation Therapeutics, a precision oncology startup based out of the Experimental Station in Wilmington has emerged with $102 million financing last week.
Cellergy Pharma, a rising cellular therapies biotechnology company, has been awarded $300,000 to fuel the development of therapies to treat severe allergic diseases.
Prelude Therapeutics, a cancer drug development firm, closed a $25 million share sale Wednesday that will help extend its funding runway.
NiKang Therapeutics has signed a new collaboration agreement with the Swiss pharmaceutical giant Roche to study a deadly liver cancer.
QPS, a leading contract research organization (CRO), recently sold its neuropharmacology unit while also expanding a U.S. research facility.
Incyte told investors two months ago that it no longer believed its $50 million deal with the Wilmington Friends School would proceed.
NEW CASTLE – Fresh off a major expansion of its operations in Delaware, the bioscience company Analytical Biological Services (ABS) has opened a new accelerator lab space that will help […]
WILMINGTON – Prelude Therapeutics is one of Delaware’s burgeoning life science success stories, and it recently announced a new milestone in signing its first partnership agreement with a major Canadian […]
Two DuPont alumnae and current top STEM executives encouraged an audience of female professionals to to lead not only with courage, but with understanding, and embrace the complexities that come with being a female leader.
The portfolio companies of The Innovation Space recently eclipsed $1 billion in funding as the not-for-profit prepares for new tenants.
Philadelphia Eagles player Kelee Ringo and his mother, Tralee Hale have partnered with Hologic to raise breast cancer awareness
I-Red University, a partnership by the University of Delaware, DESCA and InsiteHub, will aid entrepreneurs in commercializing inventions.
© 2024 Delaware Business Times